cervical cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Female patients aged 40-80 years; 2.Patients with pathologically confirmed cervical cancer at stage ?A-?A, meeting the indications for radical hysterectomy, and scheduled to undergo robot-assisted gasless vNOTES radical hysterectomy; 3.Patients classified as Grade ?-? according to the American Society of Anesthesiologists (ASA) Physical Status Classification System; 4.Patients who can cooperate in completing the visits and related examinations as specified in the protocol; 5.Patients and their family members have fully understood the purpose, process, and risks of this study, and voluntarily signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1.A history of severe pelvic or abdominal adhesions that may affect surgical procedures; 2.Comorbidity with other malignant tumors; 3.Patients with positive antibodies to human immunodeficiency virus (HIV); positive antibodies to hepatitis C virus (HCV); or positive antibodies to Treponema pallidum (syphilis) who are judged by the researcher to have a high risk of transmission; 4.Patients with severe systemic diseases who are deemed unsuitable for surgical treatment by the researcher; 5.Allergies to fluorescent tracers (such as indocyanine green); 6.Patients with mental illness who are unable to cooperate with the study; 7.Other circumstances deemed inappropriate for participation in this trial by the researcher.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Intraoperative Complication Rate;Surgical Success Rate;Postoperative Recovery Indicators;Tumor Recurrence Status;Postoperative Quality of Life; | — |
Primary
| Measure | Time frame |
|---|---|
| Fluorescent tracing effect; | — |
Countries
China
Contacts
Chengdu Women's and Children's Central Hospital